GlassScriptPhysician profile
Sharon L Satchell
NPI 1982722203
$1,449.43
in general payments reported to CMS, 2019-2025
17 companies · $596 in 2025
The $596 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $296 · 2022: $212 · 2023: $245 · 2024: $101 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843 · Education: $98.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.18 |
| Education | $98.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $192.92 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $169.82 | 2025 | Dupixent |
| Madrigal Pharmaceuticals | $156.46 | 2025 | Rezdiffra |
| Astrazeneca Pharmaceuticals LP | $151.74 | 2021-2022 | |
| Glaxosmithkline, LLC. | $147.06 | 2021-2024 | Trelegy Ellipta |
| Gilead Sciences, INC. | $144.70 | 2023-2025 | Epclusa |
| Genzyme Corporation | $143.11 | 2025 | |
| Redhill Biopharma INC. | $65.40 | 2022-2024 | Talicia |
| Takeda Pharmaceuticals U.S.A., INC. | $61.31 | 2023-2025 | Entyvio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.63 | 2021-2023 | |
| Lifescan, INC. | $43.38 | 2022 | |
| Novo Nordisk INC | $32.37 | 2025 | Wegovy |
| Ardelyx, INC. | $22.04 | 2025 | Ibsrela |
| Horizon Therapeutics Plc | $21.44 | 2023 | Krystexxa |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $19.56 | 2023 | |
| Dexcom, INC. | $14.87 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Satchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.